Skip to main content

Advertisement

SpringerLink
Log in

Isolated Extramedullary Relapse in Childhood Acute Lymphocytic Leukemia

  • Published:
Current Hematologic Malignancy Reports Aims and scope Submit manuscript

Abstract

Although the vast majority of children with acute lymphocytic leukemia attain remission with modern therapies, an unacceptably high number will suffer a disease relapse. Both the duration of remission and the site of relapse are important prognostic factors. This review focuses on leukemic relapse isolated to sites outside the bone marrow (extramedullary sites). Data from cooperative study groups as well as large single institutions are reviewed with respect to the incidence of isolated extramedullary relapse as well as the outcome following relapse. The unique anatomic and physiologic properties of the testes and the central nervous system—the two most common sites of isolated extramedullary relapse—are discussed. Finally, the evolution of leukemia therapy is reviewed, bringing into focus the goals and challenges of future therapeutic endeavors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Centers for Disease Control and Prevention, National Program of Cancer Registries (NPCR): United States Cancer Statistics (USCS). Available at http://apps.nccd.cdc.gov/uscs/. Accessed June 29, 2010.

  2. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2006. CA Cancer J Clin 2006, 56:106–130.

    Article  PubMed  Google Scholar 

  3. Land VJ, Thomas PR, Boyett JM, et al.: Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia. A Pediatric Oncology Group study. Cancer 1985, 56(1):81–87.

    Article  CAS  PubMed  Google Scholar 

  4. Gaynon PS, Trigg ME, Heerema NA et al.: Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995. Leukemia 2000, 14(12):2223–2233.

    Article  CAS  PubMed  Google Scholar 

  5. • Nguyen K, Devidas M, Cheng SC, et al.: Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children’s Oncology Group study. Leukemia 2008, 22(12):2142–2150. This article summarizes the Children’s Cancer Group (CCG) data from 1988 until 2002. With such a large cohort, this summary is able to highlight clear differences between groups based on duration of CR1, including both isolated CNS relapse and ITR. In addition, risk factors for relapse are identified, such as NCI risk stratification and initial response to induction chemotherapy.

    Article  CAS  PubMed  Google Scholar 

  6. Chessells JM, Veys P, Kempski H, et al.: Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 2003, 123(3):396–405.

    Article  PubMed  Google Scholar 

  7. • Reismuller B, Attarbaschi A, Peters C, et al.: Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria—a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Br J Haematol 2009, 144(4):559–570. This article summarizes the Berlin-Frankfurt-Münster (BFM) data from 1981 to 1999. It includes a good discussion regarding the differences in very early versus late ITR. In addition, this article includes molecular-genetic data relating to prognosis.

    Article  PubMed  Google Scholar 

  8. Gaynon PS: Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 2005, 131(5):579–587.

    Article  PubMed  Google Scholar 

  9. Gaynon PS, Qu RP, Chappell RJ, et al.: Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse—the Children’s Cancer Group Experience. Cancer 1998, 82(7):1387–1395.

    Article  CAS  PubMed  Google Scholar 

  10. Miller DR, Leikin S, Albo V, et al.: Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from Children’s Cancer Study Group. Cancer 1983, 51:1041–1049.

    Article  CAS  PubMed  Google Scholar 

  11. Nesbit ME, Robison LL, Ortega JA, et al.: Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment patient characteristics and treatment. A report for Children’s Cancer Study Group. Cancer 1980, 45:2009–2016.

    Article  PubMed  Google Scholar 

  12. Pui CH, Pei D, Sandlund JT, et al.: Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005, 23(31):7936–7941.

    Article  PubMed  Google Scholar 

  13. Pui CH, Evans WE: Treatment of acute lymphoblastic leukemia. N Engl J Med 2006, 354(2):166–178.

    Article  CAS  PubMed  Google Scholar 

  14. Nachman JB, Sather HN, Sensel MG, et al.: Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 1998, 338(23):1663–1671.

    Article  CAS  PubMed  Google Scholar 

  15. Jahnukainen K, Salmi TT, Kristinsson J, et al.: The clinical indications for identical pathogenesis of isolated and non-isolated testicular relapses in acute lymphoblastic leukemia. Acta Pediatr 1998, 87:638–643.

    Article  CAS  Google Scholar 

  16. Einsiedel HG, von Stackelberg A, Hartmann R, et al.: Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. J Clin Oncol 2005, 23(31):7942–7950.

    Article  PubMed  Google Scholar 

  17. Barredo JC, Devidas M, Lauer SJ, et al.: Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a Pediatric Oncology Group study. J Clin Oncol 2006, 24(19):3142–3149.

    Article  CAS  PubMed  Google Scholar 

  18. Ritchey AK, Pollock BH, Lauer SJ, et al.: Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1999, 17(12):3745–3752.

    CAS  PubMed  Google Scholar 

  19. Bhojwani D, Kang H, Moskowitz NP, et al.: Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children’s Oncology Group study. Blood 2006, 108(2):711–717.

    Article  CAS  PubMed  Google Scholar 

  20. Wheeler K, Richards S, Bailey C, et al.: Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia. Br J Haematol 1998, 101(1):94–103.

    Article  CAS  PubMed  Google Scholar 

  21. Guyton AC, Hall JE (eds): Textbook of Medical Physiology, edn 10. Philadelphia: W.B. Saunders Company; 2000.

    Google Scholar 

  22. Dym M, Fawcett DW. The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium. Biol Reprod. 1970, 3(3):308–26.

    CAS  PubMed  Google Scholar 

  23. Brecher ML, Weinberg V, Boyett JM, et al.: Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse. Cancer 1986, 58(5):1024–1028.

    Article  CAS  PubMed  Google Scholar 

  24. Kay HE: Testicular infiltration in acute lymphoblastic leukaemia. Br J Haematol 1983, 53(4):537–542.

    Article  CAS  PubMed  Google Scholar 

  25. Goulden N, Langlands K, Steward C, et al.: PCR assessment of bone marrow status in ‘isolated’ extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia. Br J Haematol 1994, 87(2):282–285.

    Article  CAS  PubMed  Google Scholar 

  26. van den Berg H, Langeveld NE, Veenhof CH, et al.: Treatment of isolated testicular recurrence of acute lymphoblastic leukemia without radiotherapy. Report from the Dutch Late Effects Study Group. Cancer 1997, 79(11):2257–2262.

    Article  PubMed  Google Scholar 

  27. Uderzo C, Grazia Zurlo M, Adamoli L, et al.: Treatment of isolated testicular relapse in childhood acute lymphoblastic leukemia: an Italian multicenter study. Associazione Italiana Ematologia ed Oncologia Pediatrica. J Clin Oncol 1990, 8(4):672–677.

    CAS  PubMed  Google Scholar 

  28. Gelber RD, Sallan SE, Cohen HJ, et al.: Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985. Cancer 1993, 72(1):261–270.

    Article  CAS  PubMed  Google Scholar 

  29. Balis FM, Lester CM, Chrousos GP, et al.: Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol 1987, 5(2):202–207.

    CAS  PubMed  Google Scholar 

  30. Bostrom BC, Sensel MR, Sather HN, et al.: Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood 2003, 101(10):3809–3817.

    Article  CAS  PubMed  Google Scholar 

  31. Avramis VI, Sencer S, Periclou AP, et al.: A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children’s Cancer Group study. Blood 2002, 99(6):1986–1994.

    Article  CAS  PubMed  Google Scholar 

  32. Woo MH, Hak LJ, Storm MC, et al.: Cerebrospinal fluid asparagine concentrations after Escherichia coli asparaginase in children with acute lymphoblastic leukemia. J Clin Oncol 1999, 17(5):1568–1573.

    CAS  PubMed  Google Scholar 

  33. Berg SL, Balis FM, McCully CL, et al.: Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey. Cancer Chemother Pharmacol 1993, 32(4):310–314.

    Article  CAS  PubMed  Google Scholar 

  34. Morra E, Lazzarino M, Brusamolino E, et al.: The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients. Cancer 1993, 72(2):439–445.

    Article  CAS  PubMed  Google Scholar 

  35. Morra E, Lazzarino M, Alessandrino EP, et al.: Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C). Bone Marrow Transplant 1989, 4(Suppl 1):101–103.

    PubMed  Google Scholar 

  36. Dordelmann M, Reiter A, Zimmermann M, et al.: Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1998, 20(5):444–450.

    Article  CAS  PubMed  Google Scholar 

  37. Pui CH, Cheng C, Leung W, et al.: Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003, 349(7):640–649.

    Article  PubMed  Google Scholar 

  38. Steen RG, Spence D, Wu S, et al.: Effect of therapeutic ionizing radiation on the human brain. Ann Neurol 2001, 50(6):787–795.

    Article  CAS  PubMed  Google Scholar 

  39. Gajjar A, Mulhern RK, Heideman RL, et al.: Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 1994, 12(6):1212–1216.

    CAS  PubMed  Google Scholar 

  40. Bleyer WA, Sather HN, Nickerson HJ, et al.: Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 Study by the Children’s Cancer Study Group. J Clin Oncol 1991, 9:1012–1021.

    CAS  PubMed  Google Scholar 

  41. Grundy RG, Leiper AD, Stanhope R, et al.: Survival and endocrine outcome after testicular relapse in acute lymphoblastic leukaemia. Arch Dis Child 1997, 76(3):190–196.

    Article  CAS  PubMed  Google Scholar 

  42. Chessells JM: Relapsed lymphoblastic leukaemia in children: a continuing challenge. Br J Haematol 1998, 102(2):423–438.

    Article  CAS  PubMed  Google Scholar 

  43. Borgmann A, von Stackelberg A, Hartmann R, et al.: Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Blood 2003, 101(10):3835–3839.

    Article  CAS  PubMed  Google Scholar 

  44. Saarinen-Pihkala UM, Heilmann C, Winiarski J, et al.: Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data. J Clin Oncol 2006, 24(36):5750–5762.

    Article  PubMed  Google Scholar 

  45. Claviez A, Eckert C, Seeger K, et al.: Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia. Haematologica 2006, 91(2):272–273.

    PubMed  Google Scholar 

  46. Gokbuget N, Hoelzer, D: Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects. Ann Hematol 2004, 83(4):201–205.

    Article  PubMed  Google Scholar 

  47. Parasole R, Menna G, Marra N, et al.: Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions. Leuk Lymphoma 2008, 49(8):1553–1559.

    Article  CAS  PubMed  Google Scholar 

  48. Jeha S, Gaynon PS, Razzouk BI, et al.: Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. J Clin Oncol 2006, 24(12):1917–1923.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Children’s Hospital & Research Center Oakland, 747 52nd Street, Oakland, CA, 94609, USA

    James E. Jacobs & Caroline Hastings

Authors
  1. James E. Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline Hastings
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James E. Jacobs.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacobs, J.E., Hastings, C. Isolated Extramedullary Relapse in Childhood Acute Lymphocytic Leukemia. Curr Hematol Malig Rep 5, 185–191 (2010). https://doi.org/10.1007/s11899-010-0063-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11899-010-0063-9

Keywords

Search

Navigation